We are excited to welcome Staph Leavenworth Bakali as independent Chairman of our Board of Directors. With over 30 years of senior executive and board-level experience in the life science and healthcare industries, he brings a wealth of expertise that will greatly benefit LimmaTech’s mission to address the global threat of antimicrobial resistance. Welcome to the team, Staph! #vaccines #antimicrobialresistance #team #healthcare #biotech Find the full press release here: https://lnkd.in/dMTzh3ya
LimmaTech Biologics AG’s Post
More Relevant Posts
-
#COVAXIN was developed with a single-minded focus on safety first, followed by efficacy, says #BharatBiotech https://lnkd.in/gVqqBDGF https://lnkd.in/gVqqBDGF
To view or add a comment, sign in
-
Thank you for your participation in our webinar on rapid, non-destructive quality control of lyophilized products. We hope it was helpful to you. For those who couldn't attend, here is some information about our two highlighted solutions. To learn more, read our Case Study on the Analysis of lyophilized vaccines using our SAM-Spec® multipoint NIR technology: https://lnkd.in/g3sEAZtK #ChauvinArnouxGroup #Indatech #Webinar #HypeReal #SamSpec
To view or add a comment, sign in
-
Are you attending #BPIEurope 2024? See our latest poster describing how to optimize virus yield with Exbumin, an excipient-grade recombinant albumin that sets the standard for quality, sustainability and performance for #celltherapy #genetherapy or #vaccine #biomanufacturing. #bioprocessing #innovation #sustainability #cellandgenetherapy
To view or add a comment, sign in
-
In our latest blog post, Iain Macleod Briongos explains the safety profiles of #malaria vaccines and summarizes safety information from clinical trials. https://lnkd.in/eJEeD39P #pv #drugsafety
To view or add a comment, sign in
-
A regional vaccine manufacturing approach will be more expensive for a period of time — as opposed to relying on existing global markets. “Countries and partners need to be willing to pay a premium for increased health security,” said Dr. Frederik Kristensen, managing director of the Regionalized Vaccine Manufacturing Collaborative. The collaborative aims to support existing regional vaccine manufacturing initiatives — creating more alignment than what’s currently happening, and to serve as a network to bridge the different regions so they can share lessons and technical knowledge with one another. More about the work of the CEPI (Coalition for Epidemic Preparedness Innovations)- hosted Regionalized Vaccine Manufacturing Collaborative: https://lnkd.in/dW8MVUcu
CEPI-hosted collaborative to bridge regional vaccine manufacturing
devex.com
To view or add a comment, sign in
-
Thoughts on this? >> Emergent says it has $400M in orders related to mpox outbreak >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #healthcare #biotech #productmarketing
Emergent says it has $400M in orders related to mpox outbreak
endpts.com
To view or add a comment, sign in
-
I support pharma industry leaders to execute safe, cost-effective clinical trials that accelerate delivery of life-changing treatments to patients and grow emerging market share 📈.
🚨 WHO Prequalifies Mpox Vaccine 🚨 The World Health Organization added Bavarian Nordic’s Imvanex to its prequalified vaccines list—a key step in fighting mpox. HIGHLIGHTS : - 103k+ #mpox cases in - 120+ countries since 2022. - Imvanex: 76% effective (1 dose), 82% (2 doses). Big win for Africa & global health security! 🌍💪 Learn more: 🔗 https://lnkd.in/eJj4VsMc Share your thoughts in the comment section below 👇 #Pharmaceuticals #Biotechnology #VaccineDevelopment #GlobalHealth #ClinicalTrials #ClinicalResearch #GlobalHealth #AfricaCDC #WHO #CEPI #GAVI
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Emergent says it has $400M in orders related to mpox outbreak >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #productmarketing #healthcare #pharma #pharmaceutical
Emergent says it has $400M in orders related to mpox outbreak
endpts.com
To view or add a comment, sign in
-
Today, May 14, we're excited to celebrate 𝗪𝗼𝗿𝗹𝗱 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗗𝗮𝘆! The World Drug Safety Congress Americas is proud to be partners of this global movement recognizing the power of vaccines and their positive impact on society. Join us today as we raise awareness of the vital role vaccines play in creating a healthier, safer world for all – from health equity and improving public health outcomes, to disease prevention, herd immunity, and pandemic preparedness 🌎 ❤️🩹 In honor of World Vaccine Day, enjoy 𝟳𝟬% 𝗼𝗳𝗳 𝘁𝗶𝗰𝗸𝗲𝘁𝘀 to the World Drug Safety Congress for a limited time only – saving you $2,795. Register today to help us support drug and vaccine safety, advance public health, and build safer communities. Plus, on our Vaccine Safety track, look forward to hearing from industry leaders like... ▶ Narayan Nair, Division Director for Division of Pharmacovigilance, Center for Biologics Evaluation and Research, FDA ▶ Ajinkya Inamdar, Senior Director for Global Medical Safety Strategy, BioNTech SE ... 𝘢𝘯𝘥 𝘮𝘢𝘯𝘺 𝘮𝘰𝘳𝘦! Act now – 𝘁𝗶𝗰𝗸𝗲𝘁 𝗽𝗿𝗶𝗰𝗲𝘀 𝘄𝗶𝗹𝗹 𝗻𝗲𝘃𝗲𝗿 𝗯𝗲 𝗹𝗼𝘄𝗲𝗿! Get your 70% off pass here: https://lnkd.in/gqpN6izz Pharma & biotechs, get your 𝗰𝗼𝗺𝗽𝗹𝗶𝗺𝗲𝗻𝘁𝗮𝗿𝘆 𝗽𝗮𝘀𝘀 here: https://lnkd.in/gFzSXQf9 Learn more & see how you can contribute to #WorldVaccineDay here: https://lnkd.in/eFsiixnk #WorldDrugSafety #vaccinesafety #diseaseprevention #pharmacovigilance #drugsafety
To view or add a comment, sign in
-
Back in the spotlight, Mpox was declared a global emergency by the WHO for the second time. The epicenter is now in the Democratic Republic of Congo, where more than 13,700 cases of Mpox and at least 450 deaths have occurred in 2024. Despite the availability of two vaccines, access to the most affected people remains limited. Meanwhile, other reports show that the administration of the antiviral tecovirimat did not reduce mortality in Mpox patients, which remained unchanged at 1.7% in a trial initiated in 2022. https://lnkd.in/gF9a2Tck? #monkeypox #mpox #health #globalhealth #publichealth #outbreak #medicine #biotechnology #pharmaceuticals #infectiousdiseases #WHO #CDC #FDA #USA
To view or add a comment, sign in
3,738 followers
Partner @ Pureos Bioventures | CEO-and Co-Founder, CEO-Co-founder
3moBig welcome to Staph. Happy to have you on board!